Mets Notes: Baty, Lindor, Scott, Minter, Stock
The Mets’ offseason signing of Bo Bichette displaced third baseman Brett Baty, and he’ll now take on a super utility role in Queens, MLB.com’s Anthony DiComo reports. Baty is seeing work in the outfield and at first base this spring. His experience at the hot corner and at second base makes him a viable option at both those positions, too, should Bichette or Marcus Semien need a breather or a trip to the injured list at any point.
“It’s a valuable role,” manager Carlos Mendoza tells DiComo. “We’ve been pretty honest with him. He is on board. There are going to be at-bats for him in a lot of different positions. He could play third, second and first, and now the outfield is in play.”
While Baty might not have a set position, his 2025 breakout should put him in good position to be in the lineup more often than not. The former first-round pick and top prospect shook off a terrible start to last season and finished out the year with a solid .254/.313/.435 batting line (111 wRC+) and 18 home runs. From mid-May through season’s end — a span of 370 plate appearances — Baty delivered a .266/.327/.454 batting line with 17 of his 18 long balls.
Elsewhere in Mets camp, the team is still holding out hope that star shortstop Francisco Lindor, who suffered a left hamate fracture early in camp, won’t miss much time — if he misses any at all. Lindor took batting practice yesterday for the first time since his injury, and he felt well enough after the fact to tell Jon Heyman of the New York Post he’s confident in his chances of being on the Opening Day roster.
“One hundred percent, I think I can make it for Opening Day,” said Lindor. “…We’re checking the boxes along the way.”
Lindor’s injury first came to light on Feb. 10. A day later, the Mets confirmed that he’d undergo surgery to address the issue. The team originally projected a six-week recovery, and Lindor’s surgery came 43 days prior to Opening Day. In addition to batting practice, Lindor also began playing catch this week and has yet to show any ill effects.
The recovery period on hamate fractures tends to range from four weeks on the short end to eight weeks on the longer end. Based on how things are progressing, it seems there’s reason for cautious optimism among Mets fans that the five-time All-Star and 2024 National League MVP runner-up will be in the lineup when new ace Freddy Peralta and the Mets host the Pirates and presumptive Opening Day starter Paul Skenes on March 26.
The Mets’ pitching staff is also navigating some injuries. Former top prospect Christian Scott, now 17 months removed from the 2024 Tommy John surgery that wiped out his 2025 season, hit 96 mph and tossed 48 pitches through 2 2/3 frames in an exhibition against Israel’s WBC team this week. Mendoza told the Post’s Dan Martin that the outing was “impressive, specifically touting the righty’s command in a walk-free return to the mound.
Scott, now 26 years old, made his big league debut in 2024 and posted a 4.56 ERA with 19.8% strikeout rate and 6.1% walk rate in his first taste of major league action. He’d previously tossed 42 1/3 innings with a 2.76 ERA, 33.5% strikeout rate and 7.3% walk rate at the Triple-A level. There’s no opening in the Mets’ rotation for him with Peralta, Nolan McLean, David Peterson, Clay Holmes, Kodai Senga and Sean Manaea all in the fold, but Scott will be a pivotal depth arm and one of the first names called if the Mets run into health troubles on their big league staff.
Left-handed reliever A.J. Minter, whose 2025 season ended in May due to lat surgery, pitched in a minor league game on a back field this week, Martin adds. It’s Minter’s first time back in a game setting since last year’s surgery. Previous indications have been that Minter could return at some point in May, but Mendoza indicated to Martin that late April is on the table for a possible return.
Minter signed a two-year, $22MM deal with the Mets last winter and got out to a terrific start for them. In 11 innings, he held opponents to two runs (1.64 ERA) on six hits and five walks with 14 punchouts. The 32-year-old southpaw has had his injury troubles over the years, but from 2020-25 he’s notched a sharp 2.80 earned run average with a 30% strikeout rate and 8% walk rate in 254 innings between the Braves and Mets.
In one other note related to the Mets, Tim Britton of The Athletic provides an update on non-roster invitee Robert Stock. The righty was recently with Team Israel for the World Baseball Classic but suffered some shoulder discomfort. He is out of the WBC and will be going for an MRI.
Latest On A.J. Minter
Mets left-hander A.J. Minter seems to be trending towards spending the first few weeks of the season on the injured list. He tells Anthony DiComo of MLB.com that he’s about a month behind the other pitchers in camp. He hopes to get into a Grapefruit League game before spring training is done but isn’t guaranteed to do so. The injury tracker at MLB.com lists his expected return as early May.
Minter, 32, underwent surgery to repair a torn lat in early May. It was known that his 2025 season would be ended by that surgery but his timeline beyond that hasn’t been clear. President of baseball operations David Stearns said in December that Minter was questionable for Opening Day. Now it seems that Opening Day has been ruled out. If he is healthy enough for game action near Opening Day, he should require a rehab assignment of a few weeks.
The lefty is coming off a few injury-marred seasons but had a really good run before that. From 2020 to 2023, he gave Atlanta 208 2/3 innings while allowing 2.89 earned runs per nine. He struck out 30.7% of batters faced while only giving out walks at a 7.8% pace.
In 2024, he was putting up similar numbers but made multiple trips to the IL due to left hip issues and ultimately underwent surgery. He missed the rest of that season and became a free agent, which is when the Mets signed him to a two-year, $22MM deal with an opt-out halfway through. He was healthy enough by Opening Day last year to break camp with the Mets but only tossed 11 innings before the lat strain popped up. After missing most of the 2025 campaign, he understandably decided not to opt out of the second year of his contract.
Minter will be looking to get back to that 2020-23 form with the Mets this year but it seems he will still miss a bit of time. That will leave the club to open the season without Minter in the southpaw relief group. Brooks Raley projects as the top lefty for now. They also have Bryan Hudson, whom they acquired from the White Sox a couple of weeks ago. Those are the only two healthy southpaw relievers on the roster. Sean Manaea and David Peterson are lefties but both should be in the rotation.
The Mets have a number of non-roster lefties with big league experience in camp, including Brandon Waddell, Joe Jacques, Anderson Severino and Nate Lavender. If the Mets want to bolster their depth, free agency still has some options, including Justin Wilson, Danny Coulombe, Joey Lucchesi and others. It wouldn’t be surprising to see the Mets work the waiver wire, as they were fairly active this winter in rotating players through the spots at the edge of their roster. It’s also possible some more arms become available when pitchers on minor league deals with other clubs don’t break camp and trigger opt-outs.
Photo courtesy of Reinhold Matay, Imagn Images
Mets Notes: King, Senga, Scott, Minter, Alonso
The Mets were linked to Michael King‘s market earlier this week, and the team’s interest is developed enough that the two sides had a video meeting, the New York Post’s Joel Sherman reports. Sherman adds that King’s past experience pitching in New York with the Yankees is a plus for the Mets, and the likelihood that King will sign a somewhat shorter-term contract matches the Amazins’ preference to avoid long-term commitments to pitchers.
MLB Trade Rumors did project King for a four-year, $80MM deal, while ranking the right-hander 14th on our list of the winter’s top 50 free agents. At least eight other teams besides the Mets have been connected to King, so it’s possible there’s enough interest for King to lock in a four-year guarantee just because frontline pitching is such a valued asset. That said, the 2024 season represents King’s only full season as a starter, as he was limited to 15 starts and 73 1/3 innings with the Padres last season due primarily to a pinched nerve in his shoulder, and then a bout of knee inflammation.
King felt confident enough in his market to reject San Diego’s qualifying offer, and so any team that signs the righty will have to cough up some kind of draft compensation. For a luxury tax-paying team like the Mets, the penalty for signing a qualified free agent is particularly steep, as New York would have to surrender $1MM in international bonus pool money as well as their second- and fifth-highest picks in the 2026 draft.
There has been speculation that King might be open to accepting a shorter-term contract with an opt-out clause or two, perhaps so he could re-enter the market as soon as next winter on the heels of a healthy and productive season. Giving up two picks for just one year of King carries some risk for the Mets even if that would fit their short-term window, and if King has a good enough year that he’s willing to opt out, that’s also a boost to the pitching staff. Given how New York’s rotation was beset by injuries in 2025, the Mets would probably prefer to add a pitcher with more of a proven track record of durability, but acquiring such a player could come with a higher price tag of years or money.
Speaking of the Mets’ injury-plagued rotation, president of baseball operations David Stearns gave a few updates on the staff while speaking with SNY’s Ben Krimmel, MLB.com’s Anthony DiComo (multiple links), and other reporters at the Winter Meetings. Perhaps the most noteworthy update focused on Kodai Senga, who Stearns said is feeling “as good physically as he has since that 2023 season.” The executive called this “the most encouraging development we’ve had in terms of our offseason player progression,” and said Senga was planning to return to the U.S. from Japan to throw around the end of December.
After bursting onto the MLB scene with a fantastic 2023 campaign, Senga pitched in just one game in 2024, and then more injuries and a downturn in form led to the righty tossing just 113 1/3 frames for the Mets this past season. Senga got off to a terrific start in 2025 but never seemed the same after a month-long stint on the IL due to a hamstring strain. After posting a 5.90 ERA over what ended up being his final 39 2/3 MLB innings of the season, Senga agreed to be optioned to Triple-A in September, and he allowed five earned runs over two starts and 9 2/3 innings with Syracuse.
Reports indicate that the Mets are open to trading Senga, and moving on from the last two years and $28MM of his contract. For his part, Senga wants to stay with the Mets, and his 10-team no-trade clause gives him some degree of control over his fate. Considering how the Amazins need pitching themselves, simply keeping Senga is also certainly an option, especially if the club is encouraged that he’ll be able to stay healthy. Then again, Stearns’ comments may also be read as an executive perhaps trying to calm any doubts about Senga’s health in order to help facilitate a trade.
In other rotation news, Stearns said Christian Scott will be fully ready for the start of Spring Training. Scott underwent a Tommy John/internal brace hybrid procedure in September 2024 that kept the right-hander sidelined for the entirety of the 2025 campaign. This absence made Scott a bit of a forgotten man behind other highly-touted Mets pitching prospects, yet it wasn’t long ago that Scott was himself a well-regarded arm who made a rapid climb up the minor league ladder. Scott made his MLB debut in 2024, posting a 4.56 ERA over nine starts and 47 1/3 innings before being sidelined by injury.
A.J. Minter is also returning from a season-ending surgery, as the reliever’s 2025 campaign was cut short by a torn lat muscle in May. The lengthy rehab process could extend into the 2026 season, as Stearns said it isn’t a guarantee that Minter will be ready by Opening Day, though Minter isn’t expected to miss much time if he does need to begin the year on the injured list.
The Mets have gotten little return on last offseason’s two-year, $22MM investment in Minter, and it isn’t great that there’s still a question mark hanging over his immediate availability for 2026. The veteran southpaw’s 2024 campaign was also hampered by hip problems that eventually required a season-ending surgery, so it has been some time since Minter was fully healthy. Between Minter’s status and the free agency of Edwin Diaz and several other members of the 2025 relief corps, it is no wonder that New York continues to be focused on more bullpen additions, beyond their three-year deal with Devin Williams.
Stearns also addressed Pete Alonso‘s upcoming visit to the Winter Meetings, as Alonso (who lives in Tampa) is expected to head to Orlando to conduct in-person meetings with the Orioles, Red Sox, and any other teams interested in his services. While the Mets remain interested in re-signing the Polar Bear, Stearns said “I think Pete knows us really well, and I think we know Pete really well. I think he’ll take the time here to perhaps meet with organizations he doesn’t know quite as well, and I’m sure we’ll be in touch.”
A.J. Minter To Exercise Player Option
Veteran reliever A.J. Minter will exercise his $11MM player option to return to the Mets in 2026, reports Jon Morosi of MLB Network. The left-hander originally signed a two-year, $22MM contract with New York, the second season of which was a player option. He got out to a strong start but wound up undergoing surgery to repair a torn lat in mid-May.
Minter, who turned 32 in September, wound up pitching only 11 innings with the Mets before suffering that injury. He held opponents to just two runs on six hits and five walks with 14 punchouts in that small sample. The resulting 1.64 ERA and 31.8% strikeout rate were both excellent. Minter’s average fastball dipped to a career-low 94.4 mph, however, which was a bit concerning given the fact that he was coming off season-ending hip surgery in 2024.
That’s now two straight seasons ending with surgery for Minter. Strong as his track record is, it’s hardly surprising that he’ll take a notable one-year payday to return to the Mets and hope for better health in 2026. It’s not yet clear how much longer Minter’s rehab process will span, but he’ll be around nine months removed from his operation by the time pitchers and catchers report.
If Minter is healthy for the entirety or even the majority of the 2026 campaign, there’s still potential for the southpaw to be a good value for the Mets. He’s been excellent throughout his career, save for a fluky 7.06 ERA in 29 1/3 frames during the juiced-ball season back in 2019. In 254 innings since that season, he’s logged a 2.80 earned run average with 16 saves, 99 holds, a 30.1% strikeout rate and an 8% walk rate.
Minter’s return comes on the same day that star closer Edwin Diaz has opted out of the remaining two years and $38MM on his contract. It’s of course possible that Diaz will eventually re-sign, but if he departs, Minter now stands as the most experienced high-leverage reliever in a bullpen that’ll surely be an area of focus for president of baseball operations David Stearns and the rest of the Mets front office this winter. With Diaz, Tyler Rogers, Ryan Helsley, Gregory Soto and Ryne Stanek all reaching free agency and Reed Garrett undergoing Tommy John surgery late in the season, the Mets will be in the market for almost an entirely new relief corps this winter.
A.J. Minter To Undergo Season-Ending Lat Surgery
A.J. Minter has been lost for the season, as manager Carlos Mendoza tells reporters (including Mike Puma of The New York Post) that the southpaw will undergo surgery to repair a torn lat next Monday. The Mets revealed last week that surgery was under consideration. Minter understandably attempted to exhaust other options over the past few days, but he unfortunately won’t be able to avoid going under the knife.
Mendoza also provided an update on designated hitter Jesse Winker, who landed on the 10-day injured list due to a right oblique strain this evening. Winker was diagnosed with a Grade 2 strain — one of moderate severity — and will be down for six-to-eight weeks (via Abbey Mastracco of The New York Daily News).
It’s the second consecutive injury-shortened season for Minter. The veteran reliever underwent surgery to address a left hip issue last August, ending his final year as a member of the Braves. He reached free agency for the first time over the winter. New York signed him to a surprisingly strong two-year, $22MM contract that included an opt-out after the first season. They gambled that Minter would return to form as an above-average setup man after a healthy offseason.
The early returns were encouraging. Minter couldn’t have performed much better over his first 13 outings. He allowed only two runs on six hits and five walks through 11 innings. Minter fanned 15 and recorded seven holds without surrendering a lead. He was Mendoza’s most trusted option from the left side.
Minter has been an excellent reliever throughout his career. He combined for a 3.28 ERA while striking out more than 29% of opposing hitters over parts of eight seasons with Atlanta. Minter had topped 50 innings each season between 2021-23 before dealing with significant injuries over the past two years.
New York had relied on Minter and Danny Young as their only left-handers through the first month. Both pitchers are now done for the year, as Young required Tommy John surgery over the weekend. The Mets selected the hard-throwing but erratic Génesis Cabrera to give Mendoza at least one southpaw in the bullpen. Cabrera is miscast as the top lefty on a contender, making that an area the Mets are sure to monitor over the coming weeks.
Minter is making $11MM this season. He’ll surely exercise the matching player option and hope for a healthier second year in Queens. He’s already on the 60-day injured list, as New York transferred him over when they selected Cabrera’s contract last week.
Winker may eventually end up there as well, as he’s expected to miss close to two months after tweaking his oblique in yesterday’s loss to St. Louis. He suffered the injury on a throw in a rare outfield appearance. Winker has been the Mets designated hitter against right-handed pitching. That may now fall to Brett Baty, who was recalled in the corresponding move for his IL placement. Baty was optioned a few weeks ago when Jeff McNeil returned from the IL, limiting his path to playing time at second base. Baty had just a .204/.246/.352 line over 58 plate appearances before his demotion. He’d been ice cold to begin the season but had begun to swing the bat well just before McNeil’s activation.
Mets Select Genesis Cabrera, Ty Adcock
10:30am: The Mets announced that Minter and right-hander Frankie Montas have been transferred from the 15-day IL to the 60-day IL, which opens a pair of 40-man spots for Cabrera and Adcock. Montas, like Minter, is dealing with a lat strain. His occurred during spring training, however, and the team’s hope is that he can be ready to join the rotation early this summer. He’s already spent 35 days on the IL, however, and the move to the 60-day list does not reset that clock.
9:20am: The Mets announced Thursday that they’ve selected the contracts of left-handed reliever Genesis Cabrera and right-handed reliever Ty Adcock. Lefty Brandon Waddell and righty Chris Devenski were optioned to Triple-A Syracuse to clear spots on the active roster. The Mets haven’t announced corresponding 40-man moves yet but noted in their announcement that those transactions will be revealed later today. A.J. Minter and Danny Young are both facing lengthy injury absences, so they may be moved to the 60-day injured list to open those 40-man spots. Devenski has presumably agreed to be optioned since he has at least five years of major league service time. Such players can’t be optioned to the minors without their consent.
The southpaw contingent of the Mets’ bullpen has been wiped out in a span of a few days. Up until recently, they had both Minter and Young available. Minter had a 1.64 earned run average through his first 13 appearances. Young’s 4.32 ERA through 10 outings was less impressive but he had a huge 35.1% strikeout rate and 63.2% ground ball rate, as well as a solid 8.1% walk rate. His .450 batting average on balls in play and 61.5% strand rate were both on the unlucky side, which is why his 1.40 FIP and 1.75 SIERA pointed to better results going forward.
That meant manager Carlos Mendoza had a couple of strong options from the left side but that has quickly changed. Minter landed on the 15-day IL on the weekend due to a lat strain and season-ending surgery is a possibility. Young hit the 15-day IL yesterday due to an elbow sprain and he may require Tommy John surgery. So not only are the Mets going to be without Minter and Young in the short term, but maybe for the entire season.
That is surely what has brought Cabrera up to the big leagues today. The 28-year-old signed a minor league deal with the Mets in the offseason and has been pitching for their Triple-A club. He has tossed eight innings over seven appearances for Syracuse. The 7.88 ERA in that time isn’t pretty but it’s a small sample and with a miniscule 34.9% strand rate. He has struck out 35.3% of batters faced and kept balls in play on the ground at a 50% clip, though also with a 14.7% walk rate.
Lack of control is the main knock on Cabrera. He has 275 2/3 innings of major league experience with the Cardinals and Blue Jays, having walked 11.4% of batters faced in that time. He’s been able to work around that at times with strikeouts, though he’s been inconsistent in that regard.
He had a 26% strikeout rate with the Cards in 2021, allowing him to post a 3.73 ERA. But he only punched out 16% of batters in 2022, which helped bump his ERA to 4.63. He corrected a bit in 2023 with a 24.3% strikeout rate and 4.04 ERA. It was a mixed bag last year, as his ERA dropped to 3.59 but mostly via luck. His 18.5% strikeout rate and 10% walk were both subpar figures, but he had a 78.8% strand rate. His 5.13 FIP and 4.58 SIERA both point to the ERA being a mirage.
The Jays seemingly didn’t have faith in him keeping runs off the board at that pace. They could have retained him via arbitration, with MLBTR contributor Matt Swartz projecting a modest $2.5MM salary for this year, but they cut him from the roster instead. That is what led to him landing with the Mets on a minor league deal. The injuries have created a path for him to get back to the majors. He will provide the Mets with one lefty reliever for now and the club will see which version of Cabrera they get.
The club also just needs arms generally, regardless of handedness. They are in the middle of a span where they play 13 straight games. Waddell and Devenski were just called up and combined to cover 6 1/3 innings in yesterday’s game, the former logging 4 1/3 and the latter going for two frames.
They have been swapped out for both Cabrera and Adcock. The 28-year-old Adcock has a fairly limited major league track record, with 20 innings tossed between the 2023 Mariners and 2024 Mets. He has a 5.85 ERA in that time. He has a much better 1.29 ERA in seven innings for Syracuse so far in 2025. That’s obviously a small sample but he has six strikeouts to just one walk.
His overall minor league track record isn’t huge either. The canceled 2020 season and Tommy John surgery in 2021 both put a dent in his ability to get work in. He only has 64 1/3 innings of official minor league work from 2022 to 2025, with a 3.92 ERA, 25.7% strikeout rate and 9.1% walk rate. He still has an option and can be sent back to Syracuse without being exposed to waivers if the Mets want to keep him on the 40-man as depth.
A.J. Minter Could Require Season-Ending Surgery
The Mets placed lefty A.J. Minter on the 15-day injured list due to a left lat strain this weekend, but he’ll be out far longer than 15 days. Manager Carlos Mendoza tells the Mets beat that Minter’s injury is “pretty significant” and could require surgery (video link via SNY). A final decision on surgery hasn’t been made yet, as Minter is receiving a wave of additional opinions. However, if the lefty does go under the knife, Mendoza acknowledged that the procedure would end his 2025 campaign.
It’s a brutal development for Minter, who spent the offseason rehabbing hip surgery and has been outstanding in his first 11 innings as a Met. The longtime Braves lefty has allowed only two runs on six hits and five walks with 14 strikeouts so far in 2025. That’s good for a huge 31.8% strikeout rate, albeit against a bloated 11.4% walk rate. Minter has kept a strong 48% of his opponents’ batted balls on the ground and turned in an above-average 12.4% swinging-strike rate.
Minter is one of four Mets relievers with a sub-3.00 ERA on the season (and three with a sub-2.00 mark). The Mets have seen closer Edwin Diaz struggle with command issues even as he’s gone 7-for-7 in save opportunities. Righty Ryne Stanek has also struggled with his command. The group of Reed Garrett, Jose Butto and Huascar Brazoban has been sharp thus far, but on the whole the Mets are lacking in established veterans to set up for Diaz.
More generally, the Mets are also light on lefties with Minter’s season now in jeopardy. Danny Young is the only currently healthy left-handed reliever in Mendoza’s bullpen (or on the 40-man roster). Brooks Raley just signed a one-year deal, but he’s still on the mend from last year’s Tommy John surgery. Genesis Cabrera is in Triple-A but is not on the 40-man roster and has not pitched well to begin the season.
Minter’s injury also comes with notable contractual ramifications for the Mets. A healthy version of Minter would surely have turned down the player option he faces at season’s end. He signed a two-year, $22MM deal over the winter even while recovering from hip surgery. If he’d been healthy and pitched anywhere close to his current level, he’d have been a lock to opt back into free agency.
If Minter undergoes season-ending surgery, he’d almost certainly decide to forgo that out opportunity in his contract. Even if he avoids surgery, it seems like he’ll be facing a monthslong absence, which significantly increases the chances of him exercising his $11MM player option. RosterResource already projects the Mets for $206MM of tax obligations in 2026, and that’s before factoring in player options (Minter, Frankie Montas, Pete Alonso), club options (Raley, Drew Smith) or arbitration raises (Francisco Alvarez, David Peterson and Tylor Megill, to name a few).
Mets Select Jose Urena
The Mets announced this morning that they’ve selected the contract of right-hander Jose Urena. Urena will replace southpaw A.J. Minter on the roster as the southpaw heads to the 15-day injured list due to a left lat strain. Minter’s placement on the shelf is hardly a surprise, as he exited yesterday’s game with what was termed triceps soreness at the time. The Mets have a 40-man roster spot open, so no corresponding move was necessary.
Urena, 33, has pitched in the majors for parts of ten seasons but has struggled to post average results throughout most of his career. The righty debuted with the Marlins back in 2015 and spent the first two years of his career struggling badly in the majors in a swing role, though he converted to the rotation full-time in 2017 and had a solid two-season run as an effective back-end starter. From 2017 to 2018, Urena pitched to a league average 3.90 ERA despite a microscopic 16.9% strikeout rate, though his well-below average 4.68 FIP suggested regression was likely not far away. That came to pass during his final two seasons with the Marlins, where he posted a 5.25 ERA and 5.02 FIP in 108 frames before being designated for assignment shortly after the 2020 season concluded.
In the years following his departure from Miami, Urena was typically used as a back-end starter or swingman while bouncing around various clubs outside of the playoff picture. From 2021 to 2023, the right-hander pitched for the Tigers, Rockies, Brewers, and White Sox with a combined 5.61 ERA and 5.29 FIP in 242 1/3 innings of work. He struck out just 14.6% of his opponents while walking 9.8% during that time, leaving him with weak ratios that even a 50.2% groundball rate couldn’t make up for.
Lackluster as his performance in the majors had been over the years, however, Urena managed to turn things around in Texas last year. He signed a minor league deal with the Rangers during the 2023-24 offseason and managed to crack the club’s Opening Day roster as a long reliever. He joined the rotation for a brief stretch in May and June but mostly pitched out of the bullpen, and did multi-inning relief work with intriguing effectiveness. While he still punched out just 15.1% of his opponents, his 8.4% walk rate was a bit more palatable and he maintained his strong grounder rate while adding a tick of velocity to his fastball and managing to give up fewer homers. In all, he posted a 3.80 ERA with a 4.62 FIP in 109 innings, though his 2.92 ERA in 64 2/3 frames of relief work was more impressive than his 5.08 ERA in nine starts.
Despite the improvements in his performance, Urena’s shaky work in the rotation and lack of strikeouts limited him to minor league deals once again this winter, and he eventually landed with the Mets. The righty had the ability to opt-out of his deal with the club before Opening Day but instead opted to stick with the club and pitch at Triple-A until an opportunity arose in Queens. That patience has now paid off, and he’ll join the big league roster as a multi-inning relief option or potential sixth starter should one be necessary at some point.
As for Minter, the extent of his injury won’t be known until results of the imaging he’s expected to undergo today are announced. Regardless, the Mets are clearly confident he’ll be down for long enough to justify holding him out for at least the next 15 days. That leaves Danny Young as the only left-handed option in the Mets’ bullpen for the time being, though Genesis Cabrera and Anthony Gose are both available as non-roster depth options in the minor leagues.
A.J. Minter Exits With Triceps Soreness, IL Stint Likely
Mets reliever A.J. Minter left tonight’s game against the Nationals partway through the eighth inning. After the game, manager Carlos Mendoza revealed that the left-hander exited due to soreness in his triceps. Mendoza told reporters (including Will Sammon of The Athletic) that Minter will go for imaging and that a stint on the injured list is likely.
Losing Minter for any amount of time would be a major loss for the Mets. When the southpaw signed a two-year, $22MM deal with the club this winter, some might have been surprised by the size of the contract he was able to secure. It tied him with Blake Treinen and Carlos Estévez for the third-largest contract of the offseason for a free agent reliever, and unlike Treinen’s and Estévez’s contracts, Minter’s came with an opt-out after year one. MLBTR was higher on Minter than almost any other source (we ranked him no. 34 on our Top 50 Free Agents list), and still, we only predicted he would ink a two-year, $16MM deal. Even Minter himself implied that he wasn’t exactly expecting the number he received, telling Anthony DiComo of MLB.com that he was originally planning to wait to sign until top free agent reliever Tanner Scott had set the market, but that the Mets made him an offer that was simply too good to refuse.
It’s not that Minter isn’t a talented reliever. From 2020-24, he pitched to a 2.85 ERA and 3.04 SIERA in 243 innings of work, striking out more than 30% of the batters he faced. However, he spent about half of the 2024 season on the injured list, including the final seven weeks of the season. It was a hip injury, not an arm injury, but even so, season-ending injuries are often bad news for impending free agents, especially pitchers on the wrong side of 30.
Yet, over the first four weeks of the 2025 campaign, Minter rewarded the Mets for their faith in him. His once-surprising contract quickly started to look like a bargain, and the chances of him opting out at the end of the season were growing every day. Through his first 12 games, Minter was sitting on a 1.69 ERA and a 2.69 SIERA. His strikeout and whiff rates were as impressive as ever, and his 48% groundball rate was his highest since 2020. He was a key cog in Mendoza’s bullpen, leading the team in eighth-inning appearances to help set things up for Edwin Díaz in the ninth. On Saturday, however, Minter only made it through nine pitches in the eighth, exiting in the middle of an inning for just the second time all year. It’s currently unclear how much time he’ll miss if he does indeed require an IL stint; presumably, the Mets will know more after he undergoes testing.
The Mets’ bullpen has played a critical role in their red-hot start to the season. The team is 19-8, although the offense has been surprisingly mediocre. Their starting pitching has been phenomenal (MLB-leading 2.28 ERA), but one reason their starters have been able to thrive is that they haven’t had to pitch deep into outings; Mets starters rank 18th in innings per game. That’s partly because Mendoza knows that when he pulls a great starter, he has a great crop of relievers to pick up where the starter left off. New York’s relief corps ranks third in MLB with a 2.46 ERA and second with a 3.28 Win Probability Added (per FanGraphs). Losing Minter would weaken a group that has been a huge strength early in the year. It would sting particularly badly against teams with tough left-handed batters in their lineups. Before he hurt his triceps, Minter was one of just two healthy left-handed relievers on the 40-man roster. The other, Danny Young, lacks Minter’s upside and his track record of big league success.
Player Option/Opt-Out Update: April Edition
The increasing popularity of opt-outs/player options as a means to close the gap in free agent signings and extensions has changed the face of free agency entirely. Not long ago, opt-outs were perks reserved for the game’s truly elite stars — a benefit to help differentiate nine-figure offers and secure the game’s top stars.
In 2025, they’re downright commonplace. Opt-out laden short-term deals have become a common alternative to the more conventional one-year pillow contract that a player in search of a rebound campaign might pursue. They’ll also provide a soft landing for a veteran whose market didn’t materialize as expected, even coming off a productive season. Some teams simply use them as a means of sweetening the pot even when negotiating with mid- and lower-tier free agents. The Royals gave opt-outs/player options to both Chris Stratton and Hunter Renfroe two offseasons ago. The Reds did the same with Emilio Pagan and Nick Martinez. Tucker Barnhart, Trey Mancini and Ross Stripling are just a few of the other recent examples of solid but non-star veterans to land such clauses in their free agent contracts.
At their core, opt-out provisions aren’t particularly different from club options that have been widely accepted as commonplace for decades. Teams guarantee a certain number of dollars over a certain number of years, and if the player continues performing at a high enough level, they’ll exercise a club option that’s typically locked in at a below-market price. If not, the player will be bought out and sent back to free agency. Player options and opt-outs are merely the inverse; the player/agent negotiate a certain length and annual value but reserve the right to opt back into the market if the player continues to perform at a high level. It’s two sides of the same coin, one favoring the team and the other favoring the player.
There are 16 players around the league this year who’ll have the right to opt into free agency at season’s end, depending on their performance. (Conversely, there are 27 players with club options.) We’ll periodically take a look at this group over the course of the season, as their performances will have a major impact on the 2025-26 market. For more context, you can check out our full list of 2025-26 MLB free agents as well as the first installment of our recent 2025-26 MLB Free Agent Power Rankings, wherein we rank the top 10 free agents in terms of earning power. Darragh McDonald, Anthony Franco and I recently discussed the decision process behind those rankings in the latest episode of the MLB Trade Rumors Podcast.
Onto this year’s group!
Pete Alonso, 1B, Mets | One year, $24MM remaining
Alonso looked like a good bet to opt out from the moment he agreed to terms on his front-loaded two-year, $54MM contract. That he’s been one of the best hitters on the planet in the season’s first three weeks only improves that likelihood. The 30-year-old slugger is slashing a comical .365/.474/.730 with five homers, eight doubles and more walks (12) than strikeouts (10) through his first 78 turns at the plate. Alonso is chasing pitches off the plate at a career-low 19.1% rate and is sporting the best contact rate of his career at 82.8%. He’s doing all of that with career-best marks in average exit velocity (96.3 mph), barrel rate (24.1%) and hard-hit rate (61.1%). Alonso has been an absolute monster, and the fact that he can’t receive a qualifying offer — players can only receive one in their career, and he rejected one last November — is a cherry on top of his dominant output.
Cody Bellinger, OF/1B, Yankees | One year, $25MM remaining (Bellinger receives $5MM buyout if he opts out)
Bellinger posted All-Star numbers with the 2023 Cubs, signed back for three years with a pair of opt-outs and hit well in 2024 — just not to his 2023 standard. Traded to the Yankees this past offseason, many thought he was primed for a rebound because of the favorable dimensions at Yankee Stadium. It hasn’t played out that way. Through his first 62 plate appearances, Bellinger looks more like the lost version of himself from 2021-22 than the strong performer we saw in ’23-’24. He’s hitting .185/.242/.296 with what would be career-worst strikeout and swinging-strike rates of 29% and 15.2%, respectively. When he’s made contact, it’s been loud (90.8 mph average exit velocity, 53.5% hard-hit rate) — and there’s still plenty of time to turn things around. It’s not the start he or the Yankees hoped for, however.
Shane Bieber, RHP, Guardians | One year, $16MM remaining (Bieber receives $4MM buyout if he opts out)
Bieber has yet to pitch this season as he rehabs from last year’s Tommy John surgery. Cleveland has yet to place him on the 60-day injured list, which could offer some optimism regarding his timetable for a return, but he’s not on a minor league rehab assignment yet. At last check, he was targeting a return around the All-Star break.
Alex Bregman, 3B, Red Sox | Two years, $80MM remaining (Bregman can opt out again after 2026)
Bregman has started his Boston tenure on a tear, hitting .321/.365/.564 with four big flies in 85 plate appearances. He’s been 62% better than average, by measure of wRC+, but there are still some of the same red flags he displayed early in the 2024 season. During his peak, Bregman was one of the sport’s toughest strikeouts and showed outstanding plate discipline. From 2018-23, he walked in 13.8% of his plate appearances against a puny 12.3% strikeout rate. Bregman’s walk rate fell off a cliff last season, and it hasn’t recovered so far in 2024. He’s drawn only four free passes (4.7%). More concerning, he’s fanned 18 times, leading to what would be a career-worst 21.2% strikeout rate. Bregman’s chase rate is down, and he’s still making elite contact within the strike zone, but he’s making contact on a career-low 56.5% of his swings on balls off the plate. If he keeps hitting like this, it probably won’t matter, but it’s something to watch as the season continues.
Edwin Diaz, RHP, Mets | Two years, $37MM remaining (Diaz can opt out again after 2026)
Diaz had a nice return from a 2023 season lost to a knee injury in 2024, pitching to a 3.52 ERA with a 38.9% strikeout rate against a 9.3% walk rate. It wasn’t quite his usual level of dominance, but most relievers would happily take a 39% punchout rate in a “down” season. Things aren’t going as well in 2025. Diaz’s four-seamer is sitting at a career-low 96.4 mph, per Statcast. That’s down 1.1 mph from last year’s mark and 2.5 mph from his 99.1 mph peak in 2022. If he were still overpowering opponents, it wouldn’t matter much, but Diaz has been tagged for five runs on six hits and five walks in 6 2/3 frames. That’s a 16% walk rate, and he’s already tossed four wild pitches — more than he did in 53 2/3 innings a year ago. The caveat with everyone on this list is that we’re all of 11-12% through the season, but the early trendlines aren’t good for Diaz.
Jack Flaherty, RHP, Tigers | One year, $10MM remaining (increases to $20MM once Flaherty makes 15 starts)
Flaherty’s heater is down nearly a mile per hour, and his walk rate is up from 5.9% to 10.3% … but that’s in a span of 21 1/3 innings. He’s still getting strikeouts at a plus level (28.7%), and the bottom-line results are good: 2.53 ERA. Flaherty seems healthy, which will be a big factor for him — both in terms of boosting his stock ahead of a potential return to free agency and in boosting his 2026 salary if he winds up forgoing the opt-out opportunity. If he can deliver a third straight season of 27-plus starts and a second straight year with a plus strikeout rate and low-3.00s (or even mid-3.00s) ERA, the market will likely reward him with the long-term deal that eluded him this past winter. Flaherty doesn’t turn 30 until October. He’ll have a chance at a deal ranging from four to six years in length if he comes close to replicating his 2024 performance. One potential downside: he was traded last summer and thus ineligible to receive a qualifying offer. If the Tigers contend all season, as expected, they’ll be able to make Flaherty a QO if he opts out.
Lourdes Gurriel Jr., OF, D-backs | One year, $18MM remaining
Though he’s one of the most consistent hitters in the sport, Gurriel is out to a woeful start in 2025. His D-backs are red-hot, but their current win streak comes in spite of an anemic .145/.176/.304 start from their everyday left fielder. Gurriel has some of the best contact skills in MLB, fanning in only 17.3% of his plate appearances and making contact on just shy of 90% of his swings in the zone dating back to 2022. He’s punched out in what would be a career-low 13.5% of his plate appearances this year, but he’s staring down a .121 average on balls in play. He should be due for a course correction, but it’s worth noting that he’s hitting more fly-balls and fewer line-drives than ever, which is going to naturally suppress his BABIP a bit (although certainly not to this extent). Gurriel is owed $13MM in 2026 and has a $5MM buyout on a $14MM club option for 2027. He’d need to be confident he could top not just $18MM but probably that he’d top two years and $27MM; the hefty nature of that buyout makes him a net $9MM decision for the D-backs in 2027, which seems like a price they’ll be willing to pay.
Ha-Seong Kim, SS, Rays | One year, $16MM remaining
Kim is still finishing up the rehab from last October’s shoulder surgery. He’s expected back mid-to-late May, which would give him about four months to prove he’s back to form. A healthy Kim would’ve been a coveted free agent who could’ve commanded four or more years in free agency. A plus defender at three positions and a plus runner with enough power to pop 10 to 20 homers annually, Kim will be in high demand next offseason if the shoulder injury doesn’t prove a major drain on his offensive capabilities.
Seth Lugo, RHP, Royals | One year, $15MM remaining
Lugo’s rise from reliever to starter to Cy Young finalist has been remarkable. He’s gotten decent results in 2025, with a 3.86 ERA in his first 23 1/3 innings, but his strikeout and walk rates are nowhere near last year’s marks. After fanning 21.7% of his opponents against a pristine 5.7% mark last year, the 35-year-old Lugo currently sports respective rates of 17% and 9.6%. His velocity is below par (92.2 mph average fastball) but right in line with last year’s levels. A year and $15MM should be the floor for a healthy Lugo, even if he doesn’t repeat his brilliant 2024 season. That’s the same mark that older starters like Charlie Morton, Justin Verlander, Alex Cobb and Max Scherzer (well, $15.5MM) received this past offseason. The Royals could tag him with a qualifying offer if he opts out, which would give him a tougher call on a one-year deal that should be worth more than $21MM. That said, if Lugo comes anywhere close to last year’s results, he’d turn that down in pursuit of a multi-year deal.
A.J. Minter, LHP, Mets | One year, $11MM remaining
Minter’s 94.3 mph average fastball is a career-low, but it’s only narrowly shy of his 2024 mark (94.5 mph). It’s feasible that as he further distances himself from last year’s hip surgery, that number could tick up, too. He’s pitched 8 1/3 innings, allowed a pair of runs on five hits and a walk, and punched out a dozen hitters. That’s a whopping 38.7% strikeout rate. So far, Minter is missing more bats within the strike zone than ever before; opponents have an awful 73% contact rate on his pitches in the zone (compared to the 85% league average). Minter landed two years and $22MM with an opt-out when he was coming off hip surgery. He should be able to top a year and $11MM so long as he’s healthy and pitches to his typical levels. So far, so good.
Frankie Montas, RHP, Mets | One year, $17MM remaining
Montas has yet to pitch in 2025 after suffering a lat strain during spring training. He’s yet to begin a minor league rehab stint but, like Bieber, also has not been placed on the 60-day injured list yet. The size of the Mets’ commitment to Montas this winter registered as a bit of a surprise even when he was thought to be healthy. He’ll need a strong few months to walk away from $17MM guaranteed.
Tyler O’Neill, OF, Orioles | Two years, $33MM remaining
The biggest question with O’Neill is whether he can stay healthy enough to position himself for an opt-out. He’s mashing with a .265/.339/.490 slash and two homers through 56 plate appearances. (One of those big flies extended his ludicrous MLB record of six straight Opening Days with a long ball.) He’s also missed the past couple games due to neck discomfort. O’Neill has never played in more than 138 games in a season, and he’s only twice reached 100 games in a year. (He did play 50 of 60 games in the shortened 2020 season.) O’Neill’s 21.4% strikeout rate would be a career-low, but his actual contact rate and swinging-strike rate aren’t career-best marks. It’s hard to see him sustaining that career-low strikeout rate as a result, but O’Neill’s power is substantial enough that he can be a productive hitter even running strikeout rates approaching/exceeding 30%.
Joc Pederson, DH/OF, Rangers | One year, $18.5MM remaining (Rangers can counter opt-out by exercising 2027 club option for $18.5MM)
Signed to help the Rangers remedy their 2024 ineptitude against fastballs, Pederson has instead turned in a career-worst performance against heaters (and every other offering). It’s only 16 games, but Pederson has collected just one hit against fastballs in 2025 — a single. It’s an alarming development for a hitter who carries a lifetime .244 average and .521 slugging percentage against four-seamers. Pederson has compiled an unfathomable .060/.161/.080 slash in 57 plate appearances. He’s still making a fair bit of hard contact, but most of it is resulting in grounders. His 55.6% ground-ball rate and 2.8% (!) line-drive rates are career-worst marks. There’s no earthly way he can continue to struggle this much, but he’ll need quite the turnaround for that opt-out provision to come into play.
Wandy Peralta, LHP, Padres | Two years, $8.9MM remaining (Peralta can opt out again after 2026)
Peralta posted a career-worst 13.6% strikeout rate in year one of his four-year pact with San Diego in 2024. He passed on his first opt-out opportunity, and understandably so. It’s early, but the veteran lefty has more than doubled last year’s awful 8.3% swinging-strike rate, which now sits at 16.8% through 8 1/3 innings. Peralta is generating chases on an eye-popping 40% of his pitches off the plate, and his opponents’ 44.4% contact rate on those swings is the second-best mark of his career. He’s all but shelved his four-seamer, is barely using his slider, and is leaning hard into a sinker/changeup combo. He won’t sustain a 1.08 ERA, of course, but if he keeps piling up grounders and whiffs, he’ll have a good case to opt out, even at age 34.
Trevor Story, SS, Red Sox | Two years, $55MM remaining
It’s hard to believe we’re already in year four of Story’s six-year deal with Boston — in part because we simply haven’t seen him in a Red Sox uniform all that often. The former Rockies All-Star played in only one-third of the team’s games through the first three years of the contract. Injuries have decimated Story in recent years, and he produced a middling .232/.296/.397 line when healthy enough to play from 2022-24. He’s out to a much better start in 2025, playing in 20 games (already just six shy of last year’s total) and recording a .299/.325/.442 line with three homers. A 3.8% walk rate, 30% strikeout rate and .400 BABIP through 80 plate appearances don’t bode especially well, but to his credit, Story is torching the ball; he’s averaging 90.3 mph off the bat and has even better marks in barrel rate (11.3%) and hard-hit rate (54.7%). It’s hard to see him turning down the two years and $55MM after he’s been injured so much in Boston, but he’s enjoying a fine start to the year.
Robert Suarez, RHP, Padres | Two years, $16MM remaining
Suarez’s name popped up late in the offseason rumor mill, but he was always going to be a tough trade candidate because of this two-year player option. If he performed well, he’d opt out, and if he struggled and/or got hurt, the acquiring team would be saddled with two unwanted years. Such is the nature of trading anyone with a player option/opt-out. Suarez stayed put, and the Padres have to be thrilled. He’s 8-for-8 in save opportunities, hasn’t allowed a run in nine innings, and is boasting a 31.3% strikeout rate against a 6.3% walk rate. That strikeout rate is supported by a huge 16% swinging-strike rate. Suarez looks unhittable right now, just as he has in the past when at his best. There’s a lot of season left, and things can go south in a hurry for relievers in particular, but a player couldn’t ask for a better start to a platform season.